TMC-310911
TMC-310911 Uses, Dosage, Side Effects, Food Interaction and all others data.
TMC-310911 (also known as ASC-09) is a novel investigational protease inhibitor (PI) that is structurally similar to the currently available darunavir. It is being investigated for use in HIV-1 infections. TMC-310911 has shown marked activity against a variety of HIV-1 strains, including multi-PI-resistant strains, and may be less likely to generate resistance, making it a potentially desirable therapy for both treatment-naive and PI-experienced patients.
TMC-310911 is currently being investigated, in combination with other HIV therapies and antivirals, as a potential treatment for COVID-19 caused by SARS-CoV-2.
| Trade Name | TMC-310911 |
| Generic | TMC-310911 |
| Type | |
| Formula | C38H53N5O7S2 |
| Weight | Average: 755.987 Monoisotopic: 755.338640455 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here TMC-310911
